Chambers Review
Provided by Chambers
Email address
[email protected]Contact number
(617) 261-3252Share profile
Band 4
Provided by David Lu
David Lu is a partner in the firm’s Intellectual Property practice group.
Member, Boston Patent Law Association (BPLA)
Member, Asian American Lawyers Association of Massachusetts (AALAM)
Member, Duke Boston Regional Board
Leadership Councils, Health Care and Life Sciences, Greater Boston Chamber of Commerce
Co-author, Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle. Genes Dev. 27(20): 2274-91. (2013)
Co-author, Further evidence for BRCA1 communication with the inactive X chromosome. Cell 128(5): 998-1002. (2007)
Co-author, Epstein-Barr Virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2(3):e23. (2006)
Co-author, Kaposi’s sarcoma associated herpesvirus expresses an array of novel viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. U S A 102(15): 5570-75. (2005)
Co-author, Adenovirus VA1 non-coding RNA can inhibit small interfering and microRNA biogenesis and function. Journal of Virology 78(23): 12868-76. (2004)
Co-author, Nonsense mediated decay induced by tethered human UPF3B is restricted to the cytoplasm. RNA Biology 1(1): 42-47. (2004)
Co-author, Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc. Natl. Acad. Sci. U S A 100(20): 11327-32. (2003)
Co-author, Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells. RNA 9(5): 618-30. (2003)
Suffolk University Law School
J.D.
2013
Duke University
Ph.D.
2004
Fudan University
M.S.
Fudan University
B.S.
Duke University
Certificate
2004
Provided by Chambers